We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Unveiling Altered Blood Pressure Reflexes in Women with Endometriosis: Implications for Cardiovascular Health

MedXY Editorial Team•Oct 1, 2025•Cardiology
blood pressurecardiovascular riskendometriosis

Highlights

  • Women with endometriosis display attenuated, not exaggerated, blood pressure reflexes to cold and exercise stress.
  • Cyclooxygenase (COX) inhibition with aspirin does not modify these altered pressor responses.
  • Findings suggest disrupted central autonomic integration and sympathetic outflow in endometriosis.
  • These results challenge assumptions about heightened cardiovascular reactivity in this population.

Study Background and Disease Burden

Endometriosis is a chronic gynecological disorder affecting up to 10% of reproductive-age women. Characterized by ectopic growth of endometrial tissue, it causes significant pain, infertility, and systemic inflammation. Recent epidemiological studies link endometriosis to elevated long-term risk of cardiovascular disease (CVD), including hypertension and ischemic heart disease. The mechanistic pathways connecting endometriosis and CVD remain unclear, but upregulation of cyclooxygenase (COX) enzymes in endometriotic lesions is hypothesized to influence vascular function and sympathetic nerve activity. An exaggerated pressor response—an abnormal increase in blood pressure (BP) during physical or cold stress—is a recognized risk factor for adverse cardiovascular events. This study aimed to clarify whether women with endometriosis exhibit heightened BP responses to standardized stressors, an issue of both pathophysiological interest and clinical significance.

Study Design

The investigators conducted a single-blind, randomized, crossover trial involving 20 premenopausal women: 11 with laparoscopically confirmed endometriosis (Endo group) and 9 healthy controls (HC group) without the disease. Participants underwent two stress protocols—cold pressor test (CPT) and handgrip exercise with postexercise ischemia—after ingesting either 650 mg aspirin (a nonselective COX inhibitor) or placebo. The primary endpoints were changes in mean arterial pressure (MAP) during these tests, providing a measure of sympathetic vasomotor reactivity. BP was continuously monitored at baseline and during each provocation (CPT: 3 minutes of hand submersion in 4–8°C water; handgrip: 2 minutes at 30% maximal voluntary contraction, followed by 3 minutes of postexercise ischemia).

Key Findings

Contrary to the original hypothesis, women with endometriosis demonstrated significantly attenuated pressor responses compared to healthy controls:

  • During CPT, the mean increase in MAP was 21±16 mm Hg for the Endo group versus 34±20 mm Hg for controls (P<0.01).
  • During handgrip/postexercise ischemia, MAP increased by 12±13/13±10 mm Hg in the Endo group, compared to 24±14/20±8 mm Hg in controls (P<0.01).
  • Aspirin administration had no significant effect on BP responses in either group during CPT or handgrip protocols.

These data suggest that, rather than exaggerated, the acute sympathetic and pressor responses to physical and cold stress are blunted in women with endometriosis. This attenuation was consistent across both types of physiological stress and unaffected by nonselective COX inhibition.

Expert Commentary

This study challenges the prevailing assumption that women with endometriosis are predisposed to heightened pressor and sympathetic responses due to local and systemic inflammation. The observed blunting of BP reflexes indicates possible dysregulation of central autonomic integration or diminished sympathetic outflow and vascular responsiveness. This is clinically relevant, as it suggests that traditional risk markers—such as exaggerated pressor reactivity—may not apply in this population, and that cardiovascular risk in endometriosis may operate through alternative mechanisms, possibly involving chronic inflammation, endothelial dysfunction, or altered neurovascular signaling.

Several limitations warrant mention. The sample size was modest (n=20), limiting power to detect subtler effects or subgroup differences. Subjects were relatively young and free from overt cardiovascular disease, which may restrict generalizability to older or higher-risk populations. The crossover design and rigorous physiological monitoring strengthen internal validity, but replication in larger and more diverse cohorts is advisable.

Current guidelines do not specifically address the management of cardiovascular risk in women with endometriosis. These findings underscore the need for tailored risk assessment and further mechanistic studies in this population.

Conclusion

Women with endometriosis exhibit blunted blood pressure responses to both cold exposure and isometric exercise, independent of COX inhibition. These findings suggest altered autonomic and vascular regulation, challenging assumptions about sympathetic overactivity in endometriosis. Further research is needed to elucidate the clinical implications for cardiovascular risk stratification and management in this population.

References

Williams AC, Alexander LM. Altered Blood Pressure Reflexes in Women With Endometriosis. Hypertension. 2025 Aug 1. doi: 10.1161/HYPERTENSIONAHA.125.25089. Epub ahead of print. PMID: 40747556.

Other literature for context:
– Mu F, Rich-Edwards J, Rimm EB, et al. Endometriosis and risk of coronary heart disease. Circulation. 2016;133(21):2051-2059.
– Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261-275.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Genetically Mediated LDL Cholesterol Variations and Their Limited Impact on Venous Thromboembolism RiskThis study reveals that lifelong genetic differences in LDL cholesterol levels do not significantly affect the risk of venous thromboembolism (VTE), suggesting LDL-C may not be a major causal factor in VTE development.Sep 25, 2026Enhancing Prognosis in Stable Coronary Artery Disease: Insights from a Nationwide Cohort on FFR-CTThis large nationwide study demonstrates that coronary CTA-derived FFR-CT strongly predicts future myocardial infarction, cardiovascular death, and revascularization, independent of traditional risk factors and stenosis severity, with a thrSep 25, 2026Unexpected Early Postoperative Lipid Deterioration in Cushing’s Syndrome: Implications for Cardiovascular Risk and ManagementThis study reveals that lipid profiles paradoxically worsen during the early remission phase after curative surgery for Cushing&#8217;s syndrome, highlighting a critical window for cardiovascular risk and targeted intervention.Sep 22, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing &amp; care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Whole-grain Consumption and Cardiometabolic Risk: A Meta-analysis of Randomized Trials
This meta-analysis of 87 randomized trials finds that increasing whole-grain intake is associated with improved cardiometabolic risk factors including reduced body weight, cholesterol, and blood pressure, particularly at daily intakes of 60
Sep 21, 2026
Efficacy and Safety of Low-Dose Rivaroxaban in Advanced Chronic Kidney Disease with High Cardiovascular Risk: A Comprehensive ReviewLow-dose rivaroxaban failed to reduce cardiovascular events but increased major bleeding in advanced CKD patients at high cardiovascular risk, underscoring the need for cautious anticoagulant use.Sep 21, 2026
A Synopsis of the 2025 VA/DoD Lipid Management Guideline: What Clinicians Need to KnowConcise review of the 2025 VA/DoD lipid guideline: new risk tool (PREVENT), CAC and one-time Lp(a) for risk refinement, statins for selected primary prevention groups (including people with HIV), and intensified combination therapy for verySep 19, 2026